EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of Human and Canine P‐Glycoprotein Substrates at R, P, and H Binding Sites

Neal S Burke, Katrina L Mealey iD

Journal of Veterinary Pharmacology and Therapeutics · 2026

DOI: 10.1111/jvp.70034 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2026. Verfasst von Neal S Burke und 1 weiteren Autor:innen. Beteiligte Einrichtung: Program in Individualized Medicine (PrIMe), College of Veterinary Medicine, Washington State University, Pullman, Washington, USA. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Collie Health Foundation, Palouse Club, Ott Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

P‐glycoprotein (P‐gp) greatly impacts substrate drug disposition, so much so that regulatory agencies recommend ascertaining the P‐gp status of active pharmaceutical ingredients (APIs) intended for human use. Arguably, the P‐gp status of drugs intended for canine patients is equally, if not more, important. Our research objectives were to assess whether human P‐gp substrate data can predict canine P‐gp substrate status and to explore the three previously reported binding sites within the P‐gp binding pocket, the H‐, R‐, and P‐sites. Competitive efflux assays employing cell lines expressing canine or human P‐gp were used to compare the degree of overlap or independence of the three binding sites in canine versus human P‐gp using site‐specific fluorescent P‐gp substrates rhodamine 123, calcein AM and Hoechst 33342. Because calcein AM can also be transported by multidrug resistance protein 1 (MRP1), experiments were performed to assess its potential influence on calcein AM efflux studies. Results indicate that: (i) MRP1 is either a non‐factor or negligible factor for cells expressing canine or human P‐gp respectively; (ii) determining an API's P‐gp binding site may provide clinically relevant information; and (iii) use of human P‐gp substrate data as a proxy for canine P‐gp substrate data will often prove inaccurate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP Binding Cassette Transporter, Subfamily B, Member 1AnimalsDogsHumansBinding SitesRhodamine 123FluoresceinsCell LineBenzimidazoles

Substanzen

ATP Binding Cassette Transporter, Subfamily B, Member 1Rhodamine 123Fluoresceinscalcein AMbisbenzimide ethoxide trihydrochlorideBenzimidazoles

Autor:innen und Institutionen

  • Program in Individualized Medicine (PrIMe), College of Veterinary Medicine, Washington State University, Pullman, Washington, USA.

ORCID-Profile: Katrina L Mealey

Förderung

  • Collie Health Foundation
  • Palouse Club
  • Ott Foundation

Zitieren

APA

Burke, N. S., & Mealey, K. L. (2026). Comparison of Human and Canine P‐Glycoprotein Substrates at R, P, and H Binding Sites. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.70034

Vancouver

Burke NS, Mealey KL. Comparison of Human and Canine P‐Glycoprotein Substrates at R, P, and H Binding Sites. Journal of Veterinary Pharmacology and Therapeutics. 2026. doi:10.1111/jvp.70034

BibTeX
@article{Burke2026,
  author = {Burke, Neal S and Mealey, Katrina L},
  title = {Comparison of Human and Canine P‐Glycoprotein Substrates at R, P, and H Binding Sites},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2026},
  doi = {10.1111/jvp.70034}
}
Kostenlos starten →